INTELLIA THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Georgia Keresty, Ph.D., M.P.H.

INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Georgia Keresty, Ph.D., M.P.H.”): 52,181,824 for, 11,931,333 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 33,764,684 for, 1,409,770 against, 9,714 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Description as filed by funds: Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: John M. Leonard, M.D.

INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: John M. Leonard, M.D.”): 62,998,385 for, 1,440,686 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 34,920,552 for, 253,902 against, 9,714 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

Description as filed by funds: Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: William Chase

INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: William Chase”): 62,680,787 for, 1,430,529 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 64 asset managers below reported 34,917,067 for, 257,387 against, 9,714 abstained.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.

The 68 asset managers below reported 33,144,651 for, 2,040,824 against, 0 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 62 managers: 28,925,442 for, 6,248,012 against, 9,714 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 246 managers: 12,632,927 for, 14,633,013 against, 1,665 abstained, 5,653 not voted, 31,094 1 year. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 62 managers: 6,941 for, 9,714 abstained, 35,023,171 1 year, 143,342 3 year, 0 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 243 managers: 22,204 for, 32,189 against, 1,818 abstained, 3,753 not voted, 26,958,913 1 year, 202,381 3 year, 10,783 2 year, 50 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

The 64 asset managers below reported 35,173,769 for, 685 against, 9,714 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 64 asset managers. See all 64 in the interactive database.